1. Bjermer L, Westman M, Holmstrom M, Wickman MC. The complex pathophysiology of allergic rhinitis: Scientific rationale for the development of an alternative treatment option. Allergy Asthma Clin Immunol. 2019;15:24.

2. Campion NC, Villazala-Merino S, Thwaites R, Stanek V, Killic H, Pertsinidou E. Nasal IL-13 production identifies patients with late-phase allergic responses. J Allergy Clin Immunol. 2023;152:1167-78.

3. Thompson A. Sardana N, Craig TJ. Sleep impairment and daytime sleepiness in patients with allergic rhinitis: The rol of congestion and inflammation. Ann Allergy Asthma Immunol. 2013;111:446-51.

4. Rosário Filho NA. Definição da estação polínica das gramíneas em Curitiba. Anais XXII Congresso Brasileiro de Alergia e Imunopatologia. São Paulo: ASBAI; 1990.

5. Lorsheitter ML, Vieira FM, Oliveira F. Conteúdo polínico atmosférico na cidade de Caxias do Sul, RS (Brasil) e sua correlação alergógena. Bol IG-USP Inst Geocien Univ S Paulo. 1986;17:131-9.

6. Heizaburo Y, Syuji Y, Daiju S, Kogy K, Ayako I, Toyoyuki H. Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber. Allergy and Asthma Proceedings. 2012;33:397.

7. Ricca V, Landi M, Ferrero P, Tazzer C, Canonica W, Ciprandi G, et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2000;105:54-7.

8. Dikewics MS, Wallace DV, Amrol DJ, Baroody FM, Bernstein J, Craig TJ, et al. Rhinitis 2020. A practice parameter. J Allergy Clin Immunol. 2020;146:721-67.

9. Baroody FM, Shenog D, De Tineo M, Wong IH, Naclerio RM. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009;123:1342-48.